Search Results for: covid-19
Articles
November 11, 2020
Pfizer & BioNTech Reach Agreement to Supply the EU With 200 Million Doses of COVID-19 Vaccine November 11, 2020
Pfizer and BioNTech SE recently announced they have reached an agreement with the European Commission to supply 200 million doses of their investigational….
November 5, 2020
Aerogen Collaborates on Development of More Than 15 Potential COVID-19 Inhaled Therapies November 5, 2020
Aerogen recently announced details of a broad collaborative effort to support pharmaceutical companies from around the world as they work...
October 29, 2020
Taconic Biosciences Launches Critical Model for COVID-19 Research October 29, 2020
Taconic Biosciences recently announced immediate humanized ACE2 mouse model availability for COVID-19 research. The SARS-CoV-2 virus, which causes COVID-19, uses...
October 29, 2020
Novavax Provides Phase 3 COVID-19 Vaccine Clinical Development Update October 29, 2020
Novavax, Inc. recently announced updates on its Phase 3 clinical development program of NVX-CoV2373, its COVID-19 vaccine candidate. NVX‑CoV2373 is...
October 22, 2020
First Patient Dosed in Phase 2 Trial to Treat Complications in COVID-19 October 22, 2020
Arch Biopartners Inc. recently announced it has dosed the first patient in the Phase 2 trial of its lead drug...
October 22, 2020
PepTC Vaccines Publishes Positive Preclinical Results for COVID-19 Peptide Vaccine October 22, 2020
PepTC Vaccines Limited, a subsidiary of Treos Bio Limited, recently announced the publication of positive preclinical results of its investigational...
October 22, 2020
Beroni Group Announces Successful Completion of SARS-CoV-2 Pseudovirus Neutralization Assay for Treatment of COVID-19 October 22, 2020
Beroni Group recently announced successful completion of SARS-CoV-2 pseudovirus neutralization assay in collaboration with GenScript Biotech Corporation (HKSE:1548), a leading...
October 14, 2020
Vaxart Announces Dosing First Subject in Phase 1 Clinical Trial of Its Oral Tablet COVID-19 Vaccine October 14, 2020
Vaxart, Inc. recently announced the first subject has been dosed in its Phase 1 study of VXA-CoV2-1, an oral tablet...
September 29, 2020
FSD Pharma Begins Phase 2 Clinical Trial to Evaluate FSD201 for the Treatment of Hospitalized COVID-19 Patients September 29, 2020
FSD Pharma Inc. recently announced the US FDA has authorized the initiation of a Phase 2 study for the use...
September 23, 2020
Hovione Announces Partnership to Produce Ligand's Captisol; Used in Gilead's Covid-19 Treatment September 23, 2020
Hovione recently announced the signing of a partnership agreement with Ligand to significantly ramp up the production output of Captisol, a Ligand product, which is a chemically modified cyclodextrin proven to improve the solubility….
September 15, 2020
Imanis Life Sciences Presents a First-in-Class Neutralizing Antibody Test for COVID-19 September 15, 2020
Imanis Life Sciences, LLC recently announced presentations about the development and validation of IMMUNO-COV, the first scalable, quantitative neutralizing antibody...
September 15, 2020
Vaxart Announces FDA Clearance of IND Application for Oral COVID-19 Vaccine September 15, 2020
Vaxart, Inc. recently announced the US FDA has completed its review of the company’s Investigational New Drug (IND) application for...
September 9, 2020
Vaxart’s Oral COVID-19 Vaccine Candidate Induces Potent Systemic & Mucosal Immune Responses September 9, 2020
Vaxart, Inc. recently announced pre-publication of a manuscript titled Preclinical studies of a recombinant adenoviral mucosal vaccine to prevent SARS-CoV-2...
September 9, 2020
AnGes & Brickell Biotech Announce Collaboration Agreement for the Development of a Novel DNA Vaccine Candidate for COVID-19 September 9, 2020
AnGes, Inc. recently announced a collaboration agreement with Brickell Biotech, Inc. through which Brickell has the right to develop AnGes’ proprietary….
September 3, 2020
SGS Enrolls First Patient Into Biophytis COVA Clinical Study, a COVID-19 Related Acute Respiratory Failure Treatment Clinical Trial September 3, 2020
SGS recently announce the enrollment of the first patient into an important new clinical trial designed to examine the safety, tolerability, and efficacy of….
September 2, 2020
Novavax & Canada Reach Agreement in Principle to Acquire COVID-19 Vaccine September 2, 2020
Novavax, Inc. recently announced it has reached an agreement in principle with the Government of Canada to supply up to...
September 2, 2020
First Patient Dosed in AstraZeneca’s Phase 3 COVID-19 Vaccine Trial September 2, 2020
Headlands Research is pleased to announce that on Friday, Aug. 28, its JEM Research Institute clinical trial site in Lake...
September 1, 2020
SPECIAL FEATURE - Injection Devices: Will COVID-19 Deliver Growth to the Market? September 1, 2020
Contributor Cindy H. Dubin interviews several leading companies and highlights trends in autoinjectors, pen injectors, wearable devices and connectivity, and prefilled syringes.
August 26, 2020
Catalent Signs Agreement With AstraZeneca to Expand Manufacturing Support for COVID-19 Vaccine August 26, 2020
Catalent, Inc. recently announced that Catalent Cell & Gene Therapy will provide drug substance manufacturing to AstraZeneca for the University of Oxford’s adenovirus vector-based COVID-19 vaccine….
August 26, 2020
Independent Studies Confirm Low Levels of Immune System Protein, Gelsolin, Associated With COVID-19 Severity August 26, 2020
BioAegis Therapeutics Inc. recently announced that recent publications of independent studies have reported that low levels of gelsolin are associated...
